| P2093 | author name string | T. R. Billiar | |
| | H. Lee | |
| | Y.-M. Kim | |
| | S.-J. Lee | |
| | C.-K. Kim | |
| | E. Por | |
| | H.-T. Chung | |
| | H.-Y. Oh | |
| | J.-A. Han | |
| | K.-S. Ha | |
| | S. Namkoong | |
| | Y.-G. Kwon | |
| P2860 | cites work | Inhibition of death receptor signals by cellular FLIP | Q24316446 |
| | BID: a novel BH3 domain-only death agonist | Q24320091 |
| | Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 |
| | Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex | Q28209029 |
| | Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis | Q28292299 |
| | Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis | Q28511080 |
| | Molecular mechanisms of action of steroid/thyroid receptor superfamily members | Q29547540 |
| | Biochemical pathways of caspase activation during apoptosis | Q33804316 |
| | Tumor necrosis factor signaling. | Q34185821 |
| | Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis | Q34429605 |
| | Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis | Q34451533 |
| | Regulation of lymphocyte proliferation and death by FLIP. | Q34572136 |
| | Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes | Q36058863 |
| | Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin | Q36231518 |
| | Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line | Q36507846 |
| | Paradoxical transcriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16 alpha-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes | Q36884204 |
| | Liver-enriched transcription factors uncoupled from expression of hepatic functions in hepatoma cell lines | Q40023719 |
| | Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation | Q40527800 |
| | IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins | Q40564344 |
| | Cell cycle-dependent expression of a glioma-specific chloride current: proposed link to cytoskeletal changes | Q41081250 |
| | Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver | Q41104171 |
| | Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. | Q41699009 |
| | Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes | Q42093020 |
| | Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms | Q42546244 |
| | Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. | Q43507510 |
| | Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction | Q43586550 |
| | Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes | Q44094353 |
| | Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma | Q44513297 |
| | Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes | Q44758408 |
| | A novel therapy for acute hepatitis utilizing dehydroepiandrosterone in the murine model of hepatitis | Q45118918 |
| | Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure | Q46733753 |
| | Enhancement of liver cell gap junction protein expression by glucocorticoids | Q53470419 |
| | Essential roles of the Fas ligand in the development of hepatitis | Q73206042 |
| | A broad-spectrum caspase inhibitor blocks concanavalin A-induced hepatitis in mice | Q73286902 |
| | Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition | Q73643152 |
| | Inhibition by dexamethasone of transforming growth factor beta1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction | Q74428411 |
| P433 | issue | 3 | |
| P921 | main subject | apoptotic process | Q14599311 |
| | dexamethasone | Q422252 |
| P304 | page(s) | 512–523 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Cell Death & Differentiation | Q2943974 |
| P1476 | title | Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP | |
| P478 | volume | 13 | |